Pfizer Inc (PFE)

PFE (NYSE:Drugs)
$28.80
neg -0.46
-1.57%
Today's Range: 28.72 - 29.32 | PFE Avg Daily Volume: 25,765,900
Last Update: 07/31/14 - 3:41 PM EDT
Volume: 28,734,088
YTD Performance: -4.47%
Open: $29.26
Previous Close: $29.26
52 Week Range: $27.76 - $32.96
Oustanding Shares: 6,378,718,293
Market Cap: 189,639,294,851
6-Month Chart
TheStreet Ratings Grade for PFE
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 5 4
Moderate Buy 1 1 2 2
Hold 4 4 3 2
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.08 2.08 2.05 2.06
Latest Dividend: 0.26
Latest Dividend Yield: 3.50%
Dividend Ex-Date: 07/30/14
Price Earnings Ratio: 17.28
Price Earnings Comparisons:
PFE Sector Avg. S&P 500
17.28 9.40 28.85
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-6.46% -1.38% 52.01%
GROWTH 12 Mo 3 Yr CAGR
Revenue -12.50 -0.24 -0.09
Net Income 51.20 0.38 0.11
EPS 64.40 2.14 0.46
Earnings for PFE:
EBITDA 22.78B
Revenue 51.58B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $0.55 $0.56 $2.26 $2.25
Number of Analysts 7 6 11 10
High Estimate $0.57 $0.58 $2.30 $2.38
Low Estimate $0.53 $0.54 $2.20 $2.15
Prior Year $0.58 $0.56 $2.22 $2.26
Growth Rate (Year over Year) -4.68% -0.89% 1.72% -0.14%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Jul 30, 2014 | 7:38 AM EDT

We have seen a huge correction, and we now need to look for signs that it is ending.

By

Doug Kass

 | Jul 29, 2014 | 7:43 AM EDT
Where it began.

bearishPfizer downgraded at BMO

Jul 28, 2014 | 7:56 AM EDT

PFE was downgraded to Market Perform, BMO Capital said. $31 price target. Company has limited growth prospects.

By

Jim Cramer

 | Jul 28, 2014 | 6:45 AM EDT

If you insist on playing it, recognize the 50/50 nature of the scenario.

By

Jim Cramer

 | Jul 17, 2014 | 7:10 AM EDT

If you're worried about these moves, it's time to cash out.

By

Dick Arms

 | Jul 8, 2014 | 7:00 AM EDT

Instead, in light of recent action, we should be extremely cautious.

By

Jim Cramer

 | Jul 7, 2014 | 11:18 AM EDT

A wave of M&A in the health sector makes sense.

By

Jim Cramer

 | Jul 2, 2014 | 1:25 PM EDT

Is there a case for these laggards in the Dow's jaunt to 17,000?

By

Dick Arms

 | Jun 17, 2014 | 7:00 AM EDT

I see no reason to be a buyer or an aggressive shorter.

By

Jim Cramer

 | Jun 16, 2014 | 7:32 AM EDT

Each of these 'real' American firms is now a buyout candidate because of the ridiculous U.S. tax code.

down 302 now, at 16577 the dow 30 is unchanged for 2014. roll the media hype!

Last ditch support decision above the prior swing low. If we break this zone forget about...
Cramer:  
syf
The fact that this one shook off all the flippers and stabilized is actually pretty hopefu...
Since Tuesday's low at 12.12, the VIX (SPX Volatility Index) has climbed to a high of 16.1...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.